|
|
Volumn 9, Issue 1, 1999, Pages 31-44
|
|
Long-term methotrexate (MTX) combination therapy versus MTX alone for active rheumatoid arthritis
a
|
|
Author keywords
Combination therapy; Complications; Disease modifying anti rheumatic drug; Methotrexate; Rheumatoid arthritis
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BUCILLAMINE;
C REACTIVE PROTEIN;
CORTICOSTEROID;
FOLINIC ACID;
GOLD;
METHOTREXATE;
PENICILLAMINE;
SALAZOSULFAPYRIDINE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
ERYTHROCYTE SEDIMENTATION RATE;
FEMALE;
GASTROINTESTINAL SYMPTOM;
HUMAN;
LIVER TOXICITY;
LONG TERM CARE;
MALE;
NEPHROTOXICITY;
PANCYTOPENIA;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
RHEUMATOID ARTHRITIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0032951549
PISSN: 01691163
EISSN: None
Source Type: Journal
DOI: 10.3109/bf03041257 Document Type: Article |
|
Times cited : (3)
|
|
References (31)
|
